Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,412 GBX | +2.43% | +1.75% | +18.52% |
Apr. 29 | Fitch Maintains CRH's Ratings on Strong Business Profile, Operating Performance | MT |
Apr. 25 | UK-listed drugmaker Indivior seeks shareholder nod for US listing | RE |
Sales 2024 * | 34.04B 36.57B | Sales 2025 * | 35.56B 38.2B | Capitalization | 50.8B 54.58B |
---|---|---|---|---|---|
Net income 2024 * | 3.42B 3.67B | Net income 2025 * | 3.53B 3.79B | EV / Sales 2024 * | 1.64 x |
Net Debt 2024 * | 5.05B 5.43B | Net Debt 2025 * | 4.1B 4.41B | EV / Sales 2025 * | 1.54 x |
P/E ratio 2024 * |
15.2
x | P/E ratio 2025 * |
14.5
x | Employees | 78,500 |
Yield 2024 * |
1.77% | Yield 2025 * |
1.89% | Free-Float | 93.62% |
Latest transcript on CRH plc
1 day | +0.83% | ||
1 week | +0.22% | ||
Current month | -7.62% | ||
1 month | -5.26% | ||
3 months | +11.84% | ||
6 months | +43.27% | ||
Current year | +16.60% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Manifold
CEO | Chief Executive Officer | 61 | 97-12-31 |
Jim Mintern
DFI | Director of Finance/CFO | 57 | 21-05-31 |
Randy Lake
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Fearon
BRD | Director/Board Member | 67 | 20-12-02 |
Johan Karlström
BRD | Director/Board Member | 67 | 19-09-24 |
Siobhán Talbot
BRD | Director/Board Member | 60 | 18-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 6,412 | +2.43% | 933 239 |
24-05-02 | 6,260 | +0.77% | 653,770 |
24-05-01 | 6,212 | -0.38% | 478,733 |
24-04-30 | 6,236 | -1.52% | 1,034,650 |
24-04-29 | 6,332 | +0.48% | 830,761 |
Delayed Quote London S.E., May 03, 2024 at 05:32 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.25% | 36.37B | |
-6.70% | 34.48B | |
+16.48% | 34.96B | |
+16.30% | 19.82B | |
+16.48% | 18.43B | |
+19.51% | 18.46B | |
+4.54% | 11.6B | |
+1.66% | 6.86B | |
+19.34% | 4.47B |
- Stock Market
- Equities
- CRH Stock
- CRH Stock